Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bodil Aggernaes

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The European Journal of Neuroscience|April 29, 2017
Autism: a transdiagnostic, dimensional, construct of reasoning?Bodil Aggernaes
Schizophrenia Bulletin|January 14, 2012
P50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatmentBob Oranje, Bodil Aggernaes, Hans Rasmussen, et al.
The International Journal of Neuropsychopharmacology|July 17, 2010
Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months' treatment with quetiapineBodil Aggernaes, Birte Y Glenthoj, Bjorn H Ebdrup, et al.
Journal of Autism and Developmental Disorders|August 24, 2022
Atypical Semantic Fluency and Recall in Children and Adolescents with Autism Spectrum Disorders Associated with Autism Symptoms and Adaptive FunctioningMalene Foldager, Martin Vestergaard, Jonathan Lassen, et al.
Autism Research : Official Journal of the International Society for Autism Research|May 12, 2022
Reduced mismatch negativity in children and adolescents with autism spectrum disorder is associated with their impaired adaptive functioningJonathan Lassen, Bob Oranje, Martin Vestergaard, et al.
The International Journal of Neuropsychopharmacology|August 13, 2010
Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptomsBjørn H Ebdrup, Arnold Skimminge, Hans Rasmussen, et al.
Psychiatry Research|November 16, 2010
Cognitive effects of six months of treatment with quetiapine in antipsychotic-naïve first-episode schizophreniaRune Andersen, Birgitte Fagerlund, Hans Rasmussen, et al.
Journal of Psychiatry & Neuroscience : JPN|February 27, 2010
Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophreniaBjørn H Ebdrup, Birte Glenthøj, Hans Rasmussen, et al.
Psychopharmacology|July 9, 2010
Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapineHans Rasmussen, Bjorn H Ebdrup, David Erritzoe, et al.
Archives of General Psychiatry|January 6, 2010
Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophreniaHans Rasmussen, David Erritzoe, Rune Andersen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The European Journal of Neuroscience|April 29, 2017
Autism: a transdiagnostic, dimensional, construct of reasoning?Bodil Aggernaes
Schizophrenia Bulletin|January 14, 2012
P50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatmentBob Oranje, Bodil Aggernaes, Hans Rasmussen, et al.
The International Journal of Neuropsychopharmacology|July 17, 2010
Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months' treatment with quetiapineBodil Aggernaes, Birte Y Glenthoj, Bjorn H Ebdrup, et al.
Journal of Autism and Developmental Disorders|August 24, 2022
Atypical Semantic Fluency and Recall in Children and Adolescents with Autism Spectrum Disorders Associated with Autism Symptoms and Adaptive FunctioningMalene Foldager, Martin Vestergaard, Jonathan Lassen, et al.
Autism Research : Official Journal of the International Society for Autism Research|May 12, 2022
Reduced mismatch negativity in children and adolescents with autism spectrum disorder is associated with their impaired adaptive functioningJonathan Lassen, Bob Oranje, Martin Vestergaard, et al.
The International Journal of Neuropsychopharmacology|August 13, 2010
Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptomsBjørn H Ebdrup, Arnold Skimminge, Hans Rasmussen, et al.
Psychiatry Research|November 16, 2010
Cognitive effects of six months of treatment with quetiapine in antipsychotic-naïve first-episode schizophreniaRune Andersen, Birgitte Fagerlund, Hans Rasmussen, et al.
Journal of Psychiatry & Neuroscience : JPN|February 27, 2010
Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophreniaBjørn H Ebdrup, Birte Glenthøj, Hans Rasmussen, et al.
Psychopharmacology|July 9, 2010
Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapineHans Rasmussen, Bjorn H Ebdrup, David Erritzoe, et al.
Archives of General Psychiatry|January 6, 2010
Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophreniaHans Rasmussen, David Erritzoe, Rune Andersen, et al.
Pageof 1